Hyperrab 300 unit/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26F7WRV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,053
Award facts
- Contract value 100% obligated
- $5,053.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,053.44 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial, a rabies immunoglobulin product. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with performance to be completed by January 2, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
The delivery order represents a discrete procurement of a specialized immunological product supporting military and federal healthcare needs. AmerisourceBergen's IDC with DLA Troop Support Medical encompasses a broad range of pharmaceutical commodities including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. As a critical vendor within the federal medical procurement supply chain, the company supplies healthcare products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Defense Logistics Agency is currently planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts, with intent to award multiple regional contracts to support continued pharmaceutical distribution to military and federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F7WRV?
SPE2DR26F7WRV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F7WRV worth?
The government has obligated $5,053 on SPE2DR26F7WRV.
Is contract SPE2DR26F7WRV an order under another contract?
Yes. SPE2DR26F7WRV is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WRV competed?
The extent of competition for SPE2DR26F7WRV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award